Clinical
June MIMS update
The latest in medicines news from MIMS, with new products, presentations, indications and safety changes New products Loncastuximab tesirine (Zynlonta) is an antibody-drug conjugate (ADC) targeting CD19. The monoclonal immunoglobulin …
Change up the Black Triangle Scheme, suggest authors
Most people aren’t aware of Australia’s Black Triangle Scheme – including nearly half of health care professionals However, a potential role for pharmacists could include educating their patients about it, …
Program to curb inappropriate medicines use
Monash University aims to boost health practitioners’ confidence to deprescribe unnecessary medicines through its SUPPORT-Meds program The new training initiative is being rolled out with the goal of protecting Australians …
Getting consistent with childhood vaccinations
Growth of pharmacist-administered vaccination is highlighting regulatory and funding inconsistencies, say researchers Australia needs a nationally harmonised regulatory framework for pharmacist-administered vaccinations, say researchers who have conducted a review of …
Opioid use down amid tighter scripts
The combination of wastewater and PBS data paints a picture of how opioid use is changing, with environmental health scientists suggesting tighter script controls are likely helping Oxycodone and fentanyl …
Advice amendment on acid
The TGA’s scheduling committee have recommended a change to the safety advice for azelaic acid Australian regulators have recommended altering the advice given to patients when using azelaic acid. The …
‘Enormous’ opportunity to motivate
Pharmacist-led conversations about RSV expected to increase with profession included in new NIP program, but survey findings reveal a need for more awareness One third of older Australians eligible for …
Long-term antidepressant use called into question
Antidepressants should be regularly reviewed with shared decision-making about whether to continue or stop, say experts who compiled new summary of evidence Researchers from Adelaide University and The University of …
Off-label quetiapine linked to safety concerns
Commonly prescribed medication for insomnia symptoms affects next-day performance in people with OSA, controlled trial finds Low-dose quetiapine in people with obstructive sleep apnea (OSA) and insomnia reduced OSA severity …
Influenza in the young and the old
The seasonal virus hits hard for those at each end of life’s spectrum. We look at vaccination and care tips for some of those most vulnerable to severe disease KEY …
Frailty: why medicines reviews matter
People living with frailty may benefit from more frequent medication reviews than those without, a new framework says The framework to prevent and manage frailty in older Australians has been …
Women’s confidence in contraceptive prescribing explored
Australian patients were asked how they felt about pharmacist supply and resupply of contraceptives and what would change their views Pharmacists are well-positioned and trusted for contraceptive resupply, but female …